Wow, thanks Fletch. And ugh, JNJ is going down the rabbit hole now -- they say that since tau can be a biomarker, let's focus on anti-tau drugs.

Sheesh. Let's go after a biomarker, not the cause?

"Hey, that patient has pneumonia."

"That's okay, we'll give him an experimental anti-cough drug, that ought to fix him right up."

https://www.fiercebiotech.com/biotech/hitting...rs-therapy